Table 5. Treatment and outcome features of pediatric inpatients with coronavirus disease 2019.
| Variables | Total (n = 44) | ≤ 5 yr (n = 20) | > 5 yr (n = 24) | P value | ||
|---|---|---|---|---|---|---|
| Treatments | ||||||
| Antibiotics | 42 (95) | 18 (90) | 24 (100) | 0.204a | ||
| Ceftriaxone/cefotaxime | 8 (18) | 6 (30) | 2 (8) | 0.078a | ||
| Azitromycine | 42 (95) | 18 (90) | 24 (100) | 0.205a | ||
| Antiviral treatment | 0 (0) | - | - | - | ||
| Corticosteroids | 2 (5) | 2 (10) | 0 (0) | - | ||
| Intravenous immunoglobin | 0 (0) | - | - | - | ||
| Nasal cannula oxygen therapy | 1 (2) | 1 (5) | 0 (0) | - | ||
| Inhaled corticosteroids | 1 (2) | 1 (5) | 0 (0) | - | ||
| Diagnosis | ||||||
| Asymptomatic infection | 7 (16) | 5 (25) | 2 (8) | 0.154a | ||
| Upper respiratory infection | 4 (9) | 3 (15) | 1 (4) | 0.085a | ||
| Pneumonia | 33 (75) | 12 (60) | 21 (88) | 0.068a | ||
| Outcomes | ||||||
| Intensive care | 2 (5) | 2 (10) | 0 (0) | - | ||
| Time taken to become SARS-CoV-2 RT-PCR-negative, days | 5 (3–10) | 6 (3–10) | 4 (3–9) | 0.037b | ||
| No. of samples taken to get negative SARS-CoV-2 RT-PCR results | 3 (2–4) | 3 (2–4) | 2 (2–4) | 0.061b | ||
| Total duration of fever, days | 1 (0–3) | 1 (0–3) | 1 (0–3) | 0.404b | ||
| Total duration of cough, days | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.358b | ||
| Total duration of dyspnea or tachypnea, days | 1 (0–2) | NA | 0.5 (0–2) | - | ||
| Total duration of sore throat, days | 1 (0–2) | NA | 1 (0–2) | - | ||
| Total duration of runny nose, days | 1 (0–1) | NA | 1 (0–1) | - | ||
| Total duration of fatigue or myalgia, days | 1 (0–1) | NA | 1 (0–1) | - | ||
| Total duration of headache, days | 1 (0–2) | NA | 0.5 (0–2) | - | ||
| Total duration of vomiting or diarrhea, days | 1 (0–2) | 1 (0–2) | 1 (0–2) | 0.359b | ||
| Total duration of hospitalization, days | 5 (4–10) | 6 (4–10) | 5 (4–7) | 0.018b | ||
| Total duration in intensive care unit, days | 8.5 (8–9) | 8.5 (8–9) | NA | - | ||
Values are presented as median (interquartile range) or number (%).
SARS-CoV-2 = severe acute respiratory syndrome coronavirus 2, RT-PCR = reverse-transcription polymerase chain reaction, NA = not applicable.
aχ2 test; bMann Whitney-U test.